Healthcare >> Analyst Interviews >> April 5, 2004

OUTLOOK FOR BIOPHARMACEUTICALS: THOMAS DIETZ – PACIFIC GROWTH EQUITIES LLC

THOMAS J. DIETZ is Senior Managing Director for Pacific Growth Equities, LLC. He joined the firm in 1993 as the Senior Biotechnology/Biopharmaceutical Analyst and currently serves as the Senior Managing Director in Research. His is a leading voice on Wall Street for biotechnology stocks. Prior to joining Pacific Growth, Dr. Dietz was a research faculty member at U.C. San Francisco. His research has been funded by the National Institutes of Health, the National Science Foundation and by NASA. Dr. Dietz earned a BS degree from the State University of New York, Albany, a PhD degree in Molecular Biology and Biochemistry from Washington University, and was awarded a postdoctoral fellow from the National Science Foundation. Profile
TWST: What is the focus of your coverage at Pacific Growth Equities?

Dr. Dietz: The biotechnology/biopharmaceutical team covers all of the

emerging pharmaceutical marketplace. More